 |
| Photo by Nahi Khabar 24/7 – via Personal Collection |
US Consul General Charles Goodman inaugurated the launch of Boston Scientific’s latest obesity treatment, Endoscopic Sleeve Gastroplasty (ESG), marking a significant step forward in the fight against obesity in Pakistan. The launch event brought together medical professionals, healthcare innovators, and policymakers to highlight the growing role of advanced US healthcare technology in addressing global health challenges.
A New Milestone in Obesity Care
Endoscopic Sleeve Gastroplasty (ESG) is a minimally invasive, non-surgical procedure designed to help patients reduce weight safely. It uses advanced endoscopic techniques to reshape the stomach, offering an alternative to traditional bariatric surgery. The innovation is aimed at improving patient outcomes while minimizing risks and recovery time.
US Innovation in Healthcare
Speaking at the event, Consul General Goodman emphasized that the launch reflects the strength of US-Pakistan collaboration in healthcare innovation.
“Boston Scientific’s ESG procedure demonstrates how US companies continue to pioneer groundbreaking solutions to global health issues. This technology will not only benefit patients in Pakistan but also strengthen our shared commitment to better healthcare access and innovation,” he said.
Growing Need in Pakistan
Healthcare experts at the event noted that obesity is becoming a rising concern in Pakistan, with lifestyle-related diseases such as diabetes, hypertension, and heart problems on the rise. The introduction of ESG provides a timely option for patients seeking less invasive weight management solutions.
Boston Scientific’s Role
Boston Scientific, a leading US medical technology company, continues to expand its footprint globally by introducing advanced treatments tailored to the healthcare needs of different regions. The launch of ESG in Pakistan demonstrates its commitment to advancing medical solutions that improve lives.
Post a Comment